Clinical Trial

Tubeless Strategy in Lung Transplantation: A Prospective Single-Arm Study

Study acronym: Tubeless-LTx-2
Completed
View on ClinicalTrials.gov →
Summary
This prospective, single-center, single-arm study evaluates the feasibility, safety, and rapid recovery outcomes of a tubeless strategy in lung transplantation. Consecutive eligible adult lung transplant recipients undergo lung transplantation without standard endotracheal intubation, using a laryngeal mask airway and standardized regional anesthesia and intravenous sedation protocols. The primary outcome is freedom from invasive ventilation in the operating room, defined as removal of the airway device before leaving the operating room with no reinstitution of invasive ventilation within 72 hours. Secondary outcomes include postoperative ICU length of stay, postoperative hospital length of stay, postoperative invasive ventilation requirement, postoperative complications (assessed up to 30 days), and perioperative mortality.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-08-06; most recent amendment 2026-02-24.
Status change: Not Yet Recruiting → Completed 2026-02-08
Trial Details
NCT Number NCT07120230
Lead Sponsor The First Affiliated Hospital of Guangzhou Medical University
Conditions Lung Transplant Recipient
Enrollment 30 participants
Start Date 2025-08-03
Primary Completion 2025-12-30 (estimated)
Study Completion 2026-01-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-25